Wednesday, August 31, 2022

FDA Approves First Treatment for Acid Sphingomyelinase Deficiency, a Rare Genetic Disease – Drug Information Update

Learn About a Drug Approval for ASMD

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration · 
10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA
GovDelivery logo

No comments:

Post a Comment